Drug Approval | December 18, 2023
Zydus receives final approval from the USFDA for Lacosamide Tablets
Lacosamide is indicated to treat partial-onset seizures
Lacosamide is indicated to treat partial-onset seizures
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the body
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Receives registration of Valganciclovir powder for oral solution in Germany
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Subscribe To Our Newsletter & Stay Updated
